QTMeds

Drug Database Monograph

SUNLENCA 300 mg

PENDING REVIEW

Active Ingredient: LENACAPAVIR

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 62721516

← Back to Prescription Analyzer